ID   MACL-1
AC   CVCL_6846
DR   BTO; BTO_0005048
DR   PRIDE; PXD028400
DR   Wikidata; Q54903966
RX   PubMed=19725227;
RX   PubMed=20422346;
RX   PubMed=20664973;
RX   PubMed=23404580;
RX   PubMed=35666001;
CC   Population: Brazilian.
CC   Characteristics: Original tumor belongs to the luminal subtype A; ER+, PR+ and ERBB2-, but cell line is triple negative (PubMed=23404580).
CC   Doubling time: 29 hours (PubMed=19725227).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Age at sampling from personal communication of de Goes, Alfredo Miranda.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
RX   PubMed=19725227; DOI=10.3727/096504009789735404;
RA   Correa N.C.R., Bertollo C.M., de Goes A.M.;
RT   "Establishment and characterization of MACL-1 and MGSO-3 cell lines
RT   derived from human primary breast cancer.";
RL   Oncol. Res. 17:473-482(2009).
//
RX   PubMed=20422346; DOI=10.1007/s13277-010-0029-5;
RA   Bertollo C.M., Correa N.C.R., Gomes D.A., de Souza-Fagundes E.M.,
RA   de Goes A.M.;
RT   "Effect of radiation treatment on newly established human breast
RT   cancer cell lines MACL-1 and MGSO-3.";
RL   Tumor Biol. 31:189-197(2010).
//
RX   PubMed=20664973; DOI=10.3892/or_00000907;
RA   Correa N.C.R., Bertollo C.M., Zouain C.S., de Goes A.M.;
RT   "Glyceraldehyde-3-phosphate dehydrogenase as a surface associated
RT   antigen on human breast cancer cell lines MACL-1 and MGSO-3.";
RL   Oncol. Rep. 24:677-685(2010).
//
RX   PubMed=23404580; DOI=10.3892/or.2013.2284; PMCID=PMC3621816;
RA   Correa N.C.R., Kuasne H., Faria J.A.Q.A., Seixas C.C.S., Santos I.G.D.,
RA   Abreu F.B., Nonogaki S., Rocha R.M., Aparecida Borges Silva G.,
RA   Gobbi H., Rogatto S.R., de Goes A.M., Gomes D.A.;
RT   "Genomic and phenotypic profiles of two Brazilian breast cancer cell
RT   lines derived from primary human tumors.";
RL   Oncol. Rep. 29:1299-1307(2013).
//
RX   PubMed=35666001; DOI=10.1002/pmic.202200095;
RA   Braga F.H.G., Gomez-Mendoza D.P., Lemos R.P., Rodrigues-Ribeiro L.,
RA   Raissa-Oliveira B., Prates Rodrigues A.L., Gorshkov V.A., Kjeldsen F.,
RA   Cruz J.S., Verano-Braga T.;
RT   "Proteomic analysis reveals stage-specific reprogramed metabolism for
RT   the primary breast cancer cell lines MGSO-3 and MACL-1.";
RL   Proteomics 22:e2200095.1-e2200095.11(2022).
//